Kim et al. found that surface markers co-expressed on CD31+ cells from coronary artery disease patients were downregulated in T-cell populations (CD3+) and upregulated in inflammatory cell populations (CD14+ and CD11b+) compared with in healthy controls. Here, PECAM1 is linked to coronary artery disorder.